Juan C. Jaen, President at Arcus Biosciences, Inc. (RCUS), sold 165,994 shares at $24.71 ($4.1M) on 2025-12-04, disclosed to the SEC on 2025-12-05.
Scheduled sale ($4.1M) by President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.71 | 82,997 | $2.1M | 50.0% |
| 2 | $24.71 | 82,997 | $2.1M | 50.0% |
| Total | $24.71 avg | 165,994 | $4.1M | 100% |
| Filing → |
| RCUS | SELL | 2026-01-07 | $681K | — | Filing → |
| RCUS | SELL | 2025-12-18 | $688K | — | Filing → |
| RCUS | SELL | 2025-11-19 | $2.0M | — | Filing → |